Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Compare index fund performance year by year to detect stability, volatility, and opportunities for strategic adjustments.
25,004 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Oil prices rose as the IEA deployed an historic stock draw, yet Carlyle Group’s Currie argued there’s policy response...
Rivian’s shares fell roughly 5% after unveiling the R2, erasing prior gains as the market assesses the mass-market pr...
Palantir CEO Alex Karp asserts there was never a domestic surveillance plan in the Anthropic-DoD dispute, detailing t...
With mortgage rates persistent and prices high, real estate agents helping first-time buyers chart practical loan pat...
Crypto advocates urge the Senate Banking Committee to protect DeFi protections and stablecoin rewards as hearings app...
TransFi has secured $19 million in funding to push its cross-border stablecoin payments platform into multiple region...
Tech Mahindra's Mohit Joshi says AI will transform jobs, not vanish them. This piece surveys how IT services leaders ...
ASML stock can slide even when the business remains solid. This article breaks down why drops happen, how to interpre...
A new security study shows post-hack damage outpaces the initial theft. In 2026, projects confront funding cuts, dela...
Real estate lenders and agents are adopting an education-first approach that centers on trust and client empowerment....
The U.S. Postal Service plans an 8% surcharge on package deliveries beginning April 2026, marking the first such fee ...